Delva M D
Department of Family Medicine, Queen's University, Kingston, Ont.
Can Fam Physician. 1993 Oct;39:2149-54.
Epidemiologic evidence on the risks and benefits of hormone replacement therapy (HRT) for postmenopausal women is accumulating. The apparent 50% reduction in risk of cardiovascular mortality could lead to universal HRT. Until a prospective, controlled trial is concluded, women must consider all the consequences of HRT. For the undecided, who would take HRT only to prevent osteoporosis, bone mass estimates might be warranted.
关于激素替代疗法（HRT）对绝经后女性风险和益处的流行病学证据正在不断积累。心血管疾病死亡率明显降低50%，这可能会导致HRT的广泛应用。在一项前瞻性对照试验得出结论之前，女性必须考虑HRT的所有后果。对于那些犹豫不决、仅为预防骨质疏松症才会考虑使用HRT的女性而言，或许有必要进行骨量评估。
